Microchip Technology is a Chandler, Arizona–based semiconductor maker whose microcontrollers, microprocessors, analog and power-management devices, memory, timing, and field-programmable gate arrays (FPGAs) serve automotive, industrial, aerospace and defense, and data-center markets. The stock carries broad but divided analyst coverage.
Reviewing 12 individually attributable, current targets yields a low of $75 (TD Cowen) and a high of $135 (KeyBanc), with the arithmetic mean working out to approximately $104.70 — rounded to $105 for readability. This is not an officially published consensus; it is a calculated average of the targets reviewed.
Views split along the recovery's sustainability. Bullish firms such as KeyBanc, UBS ($120), Cantor Fitzgerald ($125), and Rosenblatt ($120) emphasize the cyclical rebound and data-center exposure. Neutral voices are more cautious: Morgan Stanley ($103) and Truist ($90) are Hold/Equal Weight, while Wells Fargo recently lowered its target to $80 from $88 and TD Cowen cut to $75, citing cooled analog sentiment and limited margin-expansion visibility.
The shares last closed near $74.05, well below their 52-week high of about $105.91 and above the 52-week low near $48.52. Reaching the $105 central target therefore implies roughly 42% upside, a very large required move that would essentially retrace the stock to its prior peak.
The path hinges on whether the recovery that began in fiscal 2026 extends into fiscal 2027 and 2028. Microchip's revenue rebounded sharply — quarterly sales rose about 38% year over year in the most recent reported quarter — as the industry's inventory correction unwound. However, the stock's trailing price-to-earnings (P/E) ratio sits above 100 because earnings remain depressed, while the forward multiple is far lower, reflecting analyst expectations of much higher EPS (earnings per share) in coming years.
The stock now trades slightly above its short-term moving average but below its longer-term averages, a pattern consistent with a recovery in progress rather than a completed turnaround. The $105–$106 area, near the 52-week high, represents a significant resistance zone; a durable move toward the central target would require reclaiming that prior peak. On the downside, the low-$70s and the $48.52 cycle low serve as reference support levels.
Analyst price targets generally reflect a roughly 12-month research horizon, though individual firms differ and the actual horizon is rarely stated explicitly. Upcoming items most relevant to the target include the next quarterly earnings report, management's forward guidance, any further analyst target revisions, and broader data on semiconductor demand and inventory levels. Given the stock's recent pullback, guidance durability and margin commentary will be closely watched.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover new opportunities, keep track of existing positions, and spot shifting trends more efficiently than manual scanning alone. For investors following MCHP, such tools offer a way to complement fundamental research with systematic, data-driven market monitoring.
The $105 central target is the average of 12 verified analyst price targets spanning $75 to $135, and it implies a very large move of roughly 42% from the recent price near $74.05. The bull case rests on a genuine earnings and revenue recovery, expanding margins, and rising data-center demand; the bear case centers on inventory rebuilding, recent downgrades, and a rich trailing valuation. The unusually wide target range underscores how divided the Street remains. Whether MCHP can reach $105 will depend on whether the recovery's momentum is sustained into fiscal 2028 — a question that upcoming earnings and guidance will help answer.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, MCHP has been closely correlated with MCHPP. These tickers have moved in lockstep 99% of the time. This A.I.-generated data suggests there is a high statistical probability that if MCHP jumps, then MCHPP could also see price increases.
| Ticker / NAME | Correlation To MCHP | 1D Price Change % | ||
|---|---|---|---|---|
| MCHP | 100% | -0.63% | ||
| MCHPP - MCHP | 99% Closely correlated | -0.53% | ||
| TXN - MCHP | 81% Closely correlated | +1.86% | ||
| ADI - MCHP | 80% Closely correlated | +1.38% | ||
| NXPI - MCHP | 79% Closely correlated | -1.21% | ||
| ON - MCHP | 77% Closely correlated | -1.34% | ||
More | ||||